| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director | Director, 10% Owner
5 companies
Crandell Keith serves as a 10% Owner at SANA and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 7 buys and 4 sells. Those positions are worth an estimated $69.9M at current prices.
Historically, Crandell Keith's trades have earned a below-average insider score of 40/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -30.0%.
The biggest single holding is SANA (~$68.5M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 1,818,181 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | BOLD Boundless Bio, Inc. | 10% Owner | Sale+OE | 16,000 | $2.49 | $39,840.00 | -100% | - | - | |
| Apr 2, 2024 | BOLD Boundless Bio, Inc. | 10% Owner | Buy | 200,000 | $16.00 | $3,200,000.00 | +20.4% | -69.2% | -89.1% | |
| Feb 8, 2024 | SANA Sana Biotechnology, Inc. | 10% Owner | Buy | 1,818,181 | $5.50 | $9,999,995.50 | +17.1% | +54.1% | -51.5% | |
| Aug 12, 2021 | TWST Twist Bioscience Corp | Director | Sell | 45,000 | $107.01 | $4,815,377.39 | -37.2% | +11.1% | -50.5% | |
| Dec 22, 2020 | MASS 908 Devices Inc. | Director, 10% Owner | Buy | 300,000 | $20.00 | $6,000,000.00 | +5.5% | - | - | |
| Dec 11, 2017 | Director, 10% Owner | Buy | 266,000 | $15.00 | $3,990,000.00 | +20.9% | - | - |